Veeva Commercial Summit 2025: On quality data foundations and industry AI adoption with Karl Goossens

Digital

Interview at Veeva Summit 25 with Karl Goossens

Veeva’s latest report, The State of Data, Analytics, and AI in Commercial Biopharma, revealed a critical industry paradox: while AI adoption is very much accelerating, 89% of companies haven’t scaled more than half their AI initiatives due to poor data foundations.

At Veeva Commercial Summit in Madrid this year, web editor Nicole Raleigh spoke with Karl Goossens, General Manager of OpenData Europe at Veeva Systems, about the insights in the report, and why unlocking AI’s full value requires unified, standardised HCP and HCO data.

Goossens also discusses OpenData 2.0 and key takeaways from this year’s Commercial Summit.

Nicole Raleigh

26 November, 2025

Veeva Commercial Summit 2025

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.